Health Care
More on Health Care
Washington, D.C. (April 11, 2024)—Below is Ranking Member Jamie Raskin’s opening statement at today’s hearing entitled “Oversight of the U.S. Food and Drug Administration.”
Washington D.C. (November 1, 2023)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, and Committee Members, Rep. Maxwell Alejandro Frost and Rep. Jared Moskowitz, released the following statements announcing Committee Democrats' roundtable to examine the epidemic of gun violence and reforms to prevent the senseless loss of life:
Washington, D.C. (September 19, 2023)—Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, led Democrats in addressing the role of Pharmacy Benefit Mangers (PBMs) in high drug prices and calling for action to build on Democrats' work to lower prescription drug prices and expand access for all Americans.
Washington, D.C. (August 30, 2023)— Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the Biden-Harris Administration's announcement that ten drugs will now be eligible for price negotiation under Medicare as a direct result of the Inflation Reduction Act:
Washington, D.C. (August 16, 2023)—Today, Rep. Jamie Raskin, Ranking Member of the Committee on Oversight and Accountability, issued the following statement on the decision by the United States U.S. Fifth Circuit Court of Appeals to restrict access to the U.S. Food and Drug Administration's (FDA) approved abortion medication:
Washington, D.C. (July 19, 2023)— Rep. Katie Porter, Ranking Member of the Subcommittee on Health Care and Financial Services, led Subcommittee Democrats in affirming quality health care as the right of every person, including recipients of Deferred Action for Childhood Arrivals (DACA) protections.